These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3824534)

  • 1. Significance of ferritin as a marker in head and neck malignancies.
    Bhatavdekar JM; Vora HH; Goyal A; Shah NG; Karelia NH; Trivedi SN
    Tumori; 1987 Feb; 73(1):59-63. PubMed ID: 3824534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck.
    Maxim PE; Veltri RW
    Cancer; 1986 Jan; 57(2):305-11. PubMed ID: 3942962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tumor markers in the management of head and neck cancer.
    Rosati G; Riccardi F; Tucci A
    Int J Biol Markers; 2000; 15(2):179-83. PubMed ID: 10883893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer.
    Yabushita H; Masuda T; Ogawa A; Noguchi M; Ishihara M
    Gynecol Oncol; 1988 Jan; 29(1):66-75. PubMed ID: 3422208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
    Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
    Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of serum tumor markers (CEA, TPA, IAP and ferritin) in pulmonary tuberculosis].
    Komatsu H
    Kekkaku; 1987 Jan; 62(1):31-6. PubMed ID: 3573509
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
    Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
    Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of tumor markers in the follow up of malignant neoplasms of the head and neck].
    Grandis S; Screm MC; Cartei G
    Acta Otorhinolaryngol Ital; 1989; 9(6):599-604. PubMed ID: 2699147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of five circulating antigens in patients with head and neck squamous cell carcinoma.
    Screm MC; Grandis S; Cartei G; Cattaruzzi E
    Int J Biol Markers; 1989; 4(1):35-9. PubMed ID: 2501400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
    Lahousen M
    Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differences in assay sensitivity of selected tumor markers in head and neck neoplasms].
    Adamiak G; Jurkiewicz D; Polberg K; Konieczna M
    Otolaryngol Pol; 1995; 49 Suppl 20():99-101. PubMed ID: 9454232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy.
    Gropp C; Havemann K; Lehmann FG
    Cancer; 1978 Dec; 42(6):2802-8. PubMed ID: 728875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the CEA-Test in malignomas of the head and neck (author's transl)].
    Grossenbacher R
    Arch Otorhinolaryngol; 1979; 222(1):23-7. PubMed ID: 426719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
    Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
    Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycoprotein tumour markers in head and neck neoplasms--a consecutive study on CA-50, CA 19-9, and CEA.
    Gustafsson H; Franzén L; Grankvist K; Anniko M; Henriksson R
    J Cancer Res Clin Oncol; 1988; 114(4):394-8. PubMed ID: 3165978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.